Cécile DENIS

Publications



Articles

2023

  1. Chapron, S-A.; Kervran, C.; Da Rosa, M.; Fournet, L.; Shmulewitz, D.; Hasin, D.; Denis, C.; Collombat, J.; Monsaingeon, M.; Fatseas, M.; Gatta-Cherifi, B.; Serre, F. et al. Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample. In Drug and Alcohol Dependence, 251: 110937, 2023. doi 

2022

  1. Lartigau, M.; Ouattara, E.; Tumiotto, C.; Wodrich, H.; Busson, L.; Trimoulet, P.; Thiel, E.; Nouzille, M.; Dubos, M.; Lafon, M-E.; Gilleron, V.; Dehail, P. et al. Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France. In Journal of Clinical Virology, 149: 105134, 2022. doi 

2021

  1. Kervran, C.; Shmulewitz, D.; Serre, F.; Denis, C.; Roux, P.; Jauffret-Roustide, M.; Lalanne, L.; Hasin, D. and Auriacombe, M. Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach. In Addictive Behaviors, 116: 106797, 2021. doi 

2020

  1. Kervran, C.; Shmulewitz, D.; Serre, F.; Stohl, M.; Denis, C.; Hasin, D. and Auriacombe, M. Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special?. In Drug and Alcohol Dependence, 212: 108036, 2020. doi 

2019

  1. Auriacombe, M.; Roux, P.; Briand Madrid, L.; Kirchherr, S.; Kervran, C.; Chauvin, C.; Gutowski, M.; Denis, C.; Carrieri, M. P.; Lalanne, L. and Jauffret-Roustide, M. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. In BMJ Open, 9 (2): e023683, 2019. doi 

2018

  1. Auriacombe, M.; Moriceau, S.; Serre, F.; Denis, C.; Micoulaud-Franchi, J-A.; de Sevin, E.; Bonhomme, E.; Bioulac, S.; Fatseas, M. and Philip, P. Development and validation of a virtual agent to screen tobacco and alcohol use disorders. In Drug and Alcohol Dependence, 193: 1-6, 2018. doi 
  2. Serre, F.; Fatseas, M.; Denis, C.; Swendsen, J. and Auriacombe, M. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances. In Addictive Behaviors, 83: 123-129, 2018. doi 

2017

  1. Denis, C. M.; da Rosa, M. A. C.; Serre, F.; Kervran, C.; Henry, M.; Cherifi, B.; Auriacombe, M. and Fatseas, M. Are DSM-5 criteria for sud transferable to food addiction? IRT analysis for alcohol, tobacco, cannabis, opiate and food addiction in a clinical sample. In Drug and Alcohol Dependence, 171: e52, 2017. doi 

2016

  1. Auriacombe, M.; Debrabant, R.; Kervran, C.; Serre, F.; Taillard, J.; Philip, P.; Denis, C. and Fatséas, M. Addiction et troubles du sommeil : craving, rythmes circadiens. Une mise au point. In Médecine du Sommeil, 13 (3): 91-99, 2016. doi 
  2. Denis, C.; Fatséas, M.; Beltran, V.; Serre, F.; Alexandre, J-M.; Debrabant, R.; Daulouède, J-P. and Auriacombe, M. Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling. In Substance Abuse, 37 (1): 168-175, 2016. doi 
  3. Fatséas, M.; Hurmic, H.; Serre, F.; Debrabant, R.; Daulouède, J-P.; Denis, C. and Auriacombe, M. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions. In Psychiatry Research, 246: 656-662, 2016. doi 

2015

  1. Auriacombe, M.; Denis, C. M.; Rosa, M. A. C.; Collombat, J.; Serre, F.; Daulouede, J-P. and Fatseas, M. Validity of the eating section for the modified addiction severity index. In Drug and Alcohol Dependence, 156: e12, 2015. doi 
  2. Daulouède, J-P.; Denis, C. M.; Fatseas, M.; Beltran, V. and Auriacombe, M. Risk-taking behavior over 36-month follow-up treatment in outpatient opioid maintenance treatment program. In Drug and Alcohol Dependence, 146: e258, 2015. doi 
  3. Denis, C. M.; Fatseas, M.; Beltran, V.; Daulouede, J-P. and Auriacombe, M. Impact of 20 years harm reduction policy on HIV and HCV among opioid users not in treatment. In Drug and Alcohol Dependence, 146: e261, 2015. doi 
  4. Fatseas, M.; Collombat, J.; Rosa, M. A. C.; Denis, C. M.; Alexandre, J-M.; Debrabant, R.; Serre, F. and Auriacombe, M. Measuring “craving” in food addiction: Type, frequency, intensity. In Drug and Alcohol Dependence, 156: e66, 2015. doi 
  5. Rosa, M. A. C.; Collombat, J.; Denis, C. M.; Alexandre, J-M.; Serre, F.; Auriacombe, M. and Fatseas, M. Overlap between food addiction and DSM-5 eating disorders in a treatment seeking sample. In Drug and Alcohol Dependence, 156: e192, 2015. doi 

2014

  1. Auriacombe, M; Denis, C and Fatseas, M Commentary on Sharkow et al. (2014): Longitudinal patterns of problematic computer game use among adolescents and adults – a 2-year panel study. Welcomed and yet to come. Are we looking at what we are looking for?. In Addiciton, 2014.
  2. Auriacombe, M.; Denis, C. M.; Beltran, V.; Alexandre, J.; Debrabant, R.; Serre, F.; Daulouede, J-P. and Fatseas, M. 10-years outcome of methadone- and buprenorphine-maintained patients. Mortality, quality of life and substance use. In Drug and Alcohol Dependence, 140: e8, 2014. doi 
  3. Debrabant, R.; Fatseas, M.; Denis, C.; Taillard, J.; Philip, P. and Auriacombe, M. Qualité subjective du sommeil chez des sujets dépendants aux opiacés traités par méthadone ou buprénorphine. In Médecine du Sommeil, 11 (1): 34-35, 2014. doi 
  4. Denis, C. M.; Fleury, B.; Nalpas, B.; Crapelet, M. and Auriacombe, M. Correlation between severity of addiction and level of services received by alcohol use disorder outpatients in France. In Drug and Alcohol Dependence, 140: e48, 2014. doi 
  5. Fleury, B.; Denis, C. M.; Nalpas, B.; Crapelet, M. and Auriacombe, M. Patient motivation and 12-month treatment outcome in alcohol use disorder outpatients in France. In Drug and Alcohol Dependence, 140: e61, 2014. doi 

2013

  1. Fatseas, M; Denis, C; Debrabant, R; Mathillon, V; Beltran, V; Daulouède, J P; Balducci, M and Auriacombe, M Changes in Sleep Quality in Opiate-Dependent Subjects in Methadone and Buprenorphine Maintenance Treatment over a 12-month period. In Heroin Addiction and Related Clinical Problems, 15 (1): 39-44, 2013.

2012

  1. Denis, C.; Fatséas, M. and Auriacombe, M. Analyses related to the development of DSM-5 criteria for substance use related disorders: 3. An assessment of Pathological Gambling criteria. In Drug and Alcohol Dependence, 122 (1-2): 22-27, 2012. doi 
  2. Denis, C.; Fatséas, M.; Beltran, V.; Bonnet, C.; Picard, S.; Combourieu, I.; Daulouède, J-P. and Auriacombe, M. Validity of the Self-Reported Drug Use Section of the Addiction Severity Index and Associated Factors Used under Naturalistic Conditions. In Substance Use & Misuse, 47 (4): 356-363, 2012. doi 
  3. Denis, C.; Langlois, E.; Fatséas, M.; Auriacombe, M. and Auriacombe, M. Un modèle français de Communauté Thérapeutique ? Les communautés thérapeutiques expérimentales : Consensus des professionnels. In Psychotropes, Vol. 17 (3): 85-101, 2012. doi 
  4. Fatseas, M.; Denis, C.; Serre, F.; Dubernet, J.; Daulouède, J-P. and Auriacombe, M. Change in HIV-HCV Risk-Taking Behavior and Seroprevalence Among Opiate Users Seeking Treatment Over an 11-year Period and Harm Reduction Policy. In AIDS and Behavior, 16 (7): 2082-2090, 2012. doi 
  5. Malivert, M.; Fatséas, M.; Denis, C.; Langlois, E. and Auriacombe, M. Effectiveness of Therapeutic Communities: A Systematic Review. In European Addiction Research, 18 (1): 1-11, 2012. doi 
  6. ROSSARD, P.; RIUNE-LACABE, S.; COUSIN, P.; DENIS, C. and AURIACOMBE, M. Consommation de substances et comportements à risque au cours de l'incarcération: Enquête dans une maison d'arrêt en France. In Le Courrier des addictions, 14 (2), 2012.
  7. Serre, F; Denis, C; Fatseas, M and Auriacombe, M Santé, travail et addiction. In Le Courrier des Addictions, 14: 22-23, 2012.

2011

  1. Fatseas, M.; Denis, C.; Massida, Z.; Verger, M.; Franques-Rénéric, P. and Auriacombe, M. Cue-Induced Reactivity, Cortisol Response and Substance Use Outcome in Treated Heroin Dependent Individuals. In Biological Psychiatry, 70 (8): 720-727, 2011. doi 

Collections

2018

  1. Auriacombe, M.; Serre, F.; Denis, C. and Fatséas, M. Diagnosis of Addictions. In The Routledge Handbook of Philosophy and Science of Addiction, pages 132-144, Routledge, 1 [edition]. | New York : Routledge, 2018. | Series: Routledge handbooks in philosophy, 2018.

2016

  1. Denis, C.; Alexandre, J-M.; Serre, F.; Auriacombe, M. and Fatséas, M. 38. Outils d'évaluation pour les addictions. In Traité d'addictologie, 2016.

2014

  1. Fatséas, M.; Denis, C. and Auriacombe, M. Chapitre 14. Héroïne et opiacés. In Addictions et comorbidités, pages 237-247, Dunod, 2014.

2013

  1. Denis, C.; Lavie, E.; Fatseas, M. and Auriacombe, M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. In Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd, Chichester, UK, 2013.

2012

  1. Fatseas, M; Denis, C; Alexandre, J-M. and Auriacombe, M Les critères diagnostiques de la dépendance aux substances psycho-actives sont-ils valides pour le diagnostic du jeu pathologique ?. In Le jeu pathologique. Comprendre-Prévenir-Traiter, pages 101-105, Masson, Paris, Congrès de psychiatrie et de neurologie de langue française , 2012.

Misc

2015

  1. Denis, C. M.; Metzger, D.; Huang, L.; Trias, V.; Auriacombe, M.; Raguin, G.; Hoai, S. M. T.; Le Truong, G.; Daulouede, J-P. and O'Brien, C. P. A 6-month follow-up of the integrated treatment for opiate addiction and HIV in Vietnam. doi  WWW 

2014

  1. Auriacombe, M.; Denis, C. and Fatséas, M. Commentary on Scharkow etal. (2014): Welcomed and yet to come. Are we looking at what we are looking for?. doi 

 

 

 

 

 

 


Université de Bordeaux CNRS

CNRS UMR 6033



Participez à une étude...

A noter

SANPSY récompensé au congrès de l'Albatros


Directeur

Pr. Marc Auriacombe

Directeur adjoint

J. Taillard

Administration :

Tel : +33 (0)5 57 82 01 73

Bureau Recherche Sommeil

Tel : +33 (0)5 57 82 01 82

Bureau Recherche Addiction

Tel : +33 (0)5 56 56 17 67

Adresse :

UMR 6033 SANPSY
CH Charles Perrens
Addictologie 1er étage
(Pr. Auriacombe)
121 rue de la Béchade
CS 81285
33076 Bordeaux
France

logo SANPSY Accéder au laboratoire


Investissement d'Avenir Clinilabs Certified Site Clinilabs Certified Site